https://www.selleckchem.com/TGF-beta.html
We compared the mortality between the two groups using propensity scores derived from 17 baseline variables. We identified 1721 eligible patients, including 420 (24.4%) in the anemia group and 1301 (75.6%) in the non-anemia group. One-to-one propensity score-matching created 381 pairs. Both unmatched and matched analyses found significantly high mortality in the anemia group compared to the non-anemia group (unmatched 12.3% vs. 3.8%, log-rank p less then 0.01; matched 11.5% vs. 6.3%, log-rank p = 0.01). In ACS patients treated with an early i
إعجاب
علق
شارك
